To understand the mechanistic underpinnings of type 2 diabetes (T2D) loci mapped through GWAS, we 15 performed a tissue-specific gene association study in a cohort of over 100K individuals (n cases ⇡ 26K, 16 n controls ⇡ 84K) across 44 human tissues using MetaXcan, a summary statistics extension of PrediXcan. 17 We found that 90 genes significantly (FDR < 0.05) associated with T2D, of which 24 are previously 18 reported T2D genes, 29 are novel in established T2D loci, and 37 are novel genes in novel loci. Of these, 19 13 reported genes, 15 novel genes in known loci, and 6 genes in novel loci replicated (FDR rep < 0.05) in an 20 independent study (n cases ⇡ 10K, n controls ⇡ 62K). We also found enrichment of significant associations 21 in expected tissues such as liver, pancreas, adipose, and muscle but also in tibial nerve, fibroblasts, and 22 breast. Finally, we found that monogenic diabetes genes are enriched in T2D genes from our analysis 23 suggesting that moderate alterations in monogenic (severe) diabetes genes may promote milder and later 24 onset type 2 diabetes. 25 45 human hepatocytes [17]. Moreover, Sort1 knockdown and overexpression studies in mice altered LDL-C 46 and very low density lipoprotein (VLDL) levels [17]. In a study of the FTO locus harboring the strongest 47 association with obesity, researchers observed a long-range interaction between the associated intronic 48 region of FTO and the promoter of IRX3, a downstream transcription factor located ⇡ 500 kb away, 49 but not with the FTO promoter [18]. Perturbing IRX3 expression in the hypothalamus also reduced 50 body mass accumulation in the background of a high fat diet and improved measures of metabolic health 51 [18]. Obesity-associated SNPs within the locus were also significantly associated with IRX3 expression 52 in human cerebellum but not with FTO expression [18]. These examples demonstrate that regulatory 53 consequences of disease-associated variants may not solely target the putative causal gene reported from 54 GWAS, if at all. Thus, it is unclear to what extent regulatory genetic variation supports the putative 55 causal gene at disease-associated loci. We sought to address this problem systematically by applying 56 a statistical method that leverages the wealth of genotype and expression data from large-scale eQTL 57 mapping studies.
Introduction 26
Type 2 diabetes (T2D) is a complex disease characterized by impaired glucose homeostasis resulting from 27 dysfunction in insulin-secreting pancreatic islets and decreased insulin sensitivity in peripheral tissues 28 [1] . In addition to environmental factors such as a sedentary lifestyle and poor diet, genetic susceptibility Table 1 . Significant association between predicted expression and T2D. Bonferroni corrected for all gene tissue pairs tested. When multiple tissues were significant, the top tissue result is shown.
Significant genes enriched in relevant pathways 112 To glean insight into relevant biological pathways, we performed a gene set enrichment analysis on the set 113 of FDR  0.05 significant genes and found top Gene Ontology Biological Process (GO:BP) pathways to 114 involve the insulin-secretory pancreatic -cell (e.g. negative regulation of type B pancreatic cell apoptotic 115 process, Supplemental Figure S4 ). This was also the case when we restricted this analysis to the set of 116 reported T2D genes ( Supplemental Table S5 ). However, we found fatty acid homeostasis to be a top 117 pathway enriched among the set of novel T2D genes implicated in our MetaXcan analysis, underscoring 118 a genetic contribution from variants regulating gene expression in insulin-responsive peripheral tissues 119 (Supplemental Table S6 ).
120
Enrichment of genes reported for related traits 121 We also explored shared etiology with other complex diseases by comparing our set of MetaXcan-122 implicated T2D genes with sets of genes implicated by GWAS listed in the NHGRI-EBI online catalogue.
123
Unsurprisingly, we found that the set of MetaXcan-significant genes nearest to associated SNPs from the 124 trans-ethnic study (i.e. reported T2D genes) were enriched among gene sets annotated to type 2 diabetes . Red line denotes the Bonferroni significance threshold adjusted for the total number of tests performed across all tissue models (p< 2.4 10 7 ). Positions correspond to transcription start sites. (Lower ) Manhattan plot showing SNP associations from the trans-ethnic meta-analysis of GWAS. Red line denotes marginal significance threshold (p = 5 ⇥ 10 6 ). Y-axis is truncated at log 10 (p) = 50 to enable comparison with MetaXcan profile as chromosome 10 association at TCF7L2 locus would dominate plot. QQ-plot of tissue-level associations across 44 models for (B) total genes, (C) genes within 1 Mb of GWAS associations (p < 5 ⇥ 10 6 ), and (D) genes greater that 1 Mb away from GWAS associations. finger protein 703) and ZNF771 (zinc finger protein 771), PXMP2 (peroxisomal membrane protein 2) 156 and PPIB (peptidylprolyl isomerase B)( Supplementary Table S3 ).
157
Enrichment in diabetes relevant tissues 158 We sought to investigate the role of di↵erent tissues in the pathogenesis of T2D by looking at the 159 enrichment of significant associations in each tissue. We used the average significance (represented by 160 the squared Z-score averaged across all genes) as a measure of enrichment but recognized the need to 161 account for di↵erential power to detect associations given the di↵erent sample sizes used in the training of 162 di↵erent tissue models. The enrichment increases as sample size increases (Spearman's rank correlation 163 ⇢ = 0.887, p = 4.69 ⇥ 10 16 ) ( Figure 3 ). As expected, we found liver, pancreas, subcutaneous adipose 164 tissue, and skeletal muscle ranked higher than other tissues with similar sample size.
165
However, when we examined individual genes, many of established T2D genes (e.g. TCF7L2, WFS1, Among the top 20 genes (stringent Bonferroni significant) only three (RCCD1, CWF19L1, and 173 AP3S2 ) show significance across many tissues. For the majority of genes, the association is only de-174 tected in a handful of tissues (Figure 3 B) . This is probably a consequence of the context specificity of 175 regulatory mechanisms that lead to disease in the pathogenic tissue. However, because of sharing of reg-176 ulatory mechanisms across tissues and because we are examining a large number of tissues, i.e. multiple 177 experiments, we are able to detect the relevant regulatory mechanism, which may or may not be the 178 causal tissue, but happened to have the right environmental or context trigger.
179
Given the complexity of gene regulation such as context specificity, feedback loops, as well as hidden 180 confounders in the expression data, the regulatory activity may not always be detected in the tissue most B. Significance of top T2D-associated genes across tissues. Z-scores of the association between predicted expression levels and T2D case control status across 44 human tissues is shown. Except for RCCD1, CWF19L1, and AP3S2, genes are associated in only a few tissues indicating context specificity. The size of the circles represent the magnitude of the Z-score. Blue color represents positive association, i.e. increase in expression level associated with increase in T2D risk. Red color represents negative association. The intensity of the color represents the performance of the prediction models (correlation squared between predicted and observed expression levels cross-validated in the training samples). Therefore larger circles indicate more significant associations whereas darker colors indicate higher prediction confidence. Missing circles mean that the association was not performed because of missing model (no good prediction model) or because the prediction SNPs were absent in the GWAS. . Green circles correspond to a subset of the monogenic gene list, considered to cause diabetes as the main phenotype. We see that monogenic genes are enriched in significant genes (away from the gray line) and that the subset where the phenotype is diabetes is even more enriched (further away from the gray identity line). OMIM (gray +) and ClinVar (red +) list yield similar enrichments. p-values below 10 10 have been capped to 10 10 for better visualization.
MetaXcan provides a principled way to prioritize e↵ector genes in known trait-associated loci. To imple-198 ment this, we defined 68 non-overlapping windows comprising known T2D-associated SNPs (see details 199 in Methods) which we refer to as T2D-loci. We profiled these loci according to the strength, number, 200 and proximity of predicted gene expression associations. We used two thresholds for the multiple test 201 correction: one very stringent that accounts for the total number of tissue/gene pairs (genome-wide 202 p = 0.05/204, 981 = 2.4 ⇥ 10 7 ) and another one more appropriate for a locus-specific analysis that 203 accounts for the total number of tests within the locus (locus-wide p threshold varies by locus).
204
We found that 33 loci had at least one locus-wide significant association ( Supplementary Table S9 ). 5A). In addition to JAZF1, we find that increased expression of HOXA11, an upstream transcription 215 factor-encoding gene, is associated with T2D at the locus-wide level ( Figure 5A ).
216
To gain further insight into these associations, we examined the e↵ect of the SNPs that make up the 217 prediction models on the phenotype and on the expression of the corresponding gene. We find that many 218 of the SNPs in the prediction models for JAZF1 fall within eQTL association peaks in these tissues and 219 are themselves significantly associated with T2D ( Figure 5B-C) . Moreover, the disease-promoting alleles 220 for these SNPs are associated with decreased expression of JAZF1 ( Figure 5B-C) . However, the lead SNP 221 in the JAZF1 prediction models (rs1635852) is also present in the model for HOXA11 expression where 222 the disease-promoting allele associates with increased gene expression ( Figure 5B-D) .
CDKAL1 locus 224
The reported gene, CDKAL1, showed no significant association whereas predicted gene expression of 225 nearby genes ID4 and SOX4 associated with T2D ( Figure 5E ). Although there were multiple eQTL 226 association peaks evident among the set of SNPs in the prediction models for these genes, there was only 227 one GWAS peak in this region. Moreover, the disease-promoting alleles of the model SNPs within the 228 shared peak associated with a decrease in gene expression 5F-G.
229
AP3S2, PRC1, and VPS33B locus 230 We observed the most tissue-level gene associations at a region spanning three reported T2D genes: 231 AP3S2, PRC1, and VPS33B ( Figure 6A ). Although each of these putative T2D genes were supported 232 by our MetaXcan analysis, the most significant associations at this region corresponded to a novel T2D 233 gene, RCCD1, with increased expression of this gene associated with T2D( Figure 6A , Table S1 , and 234 Supplementary Table S9 ).
235
The only other gene in this interval supported by at least one genome-wide significant association was 236 the reported T2D gene AP3S2 where increased expression was associated with disease status. Moreover, 237 increased expression of AP3S2 in 29 tissue models associated with T2D at the window-level threshold 238 ( Figure 6A and Supplementary Table S9 ).
239
The variants underlying the top associations for RCCD1 and AP3S2 are independent from each 240 other as the SNPs constituting the respective predictive models are not in linkage disequilibrium with 241 each other ( Figure 6F ). The genetically predicted gene expression values for RCCD1 in brain cortex 242 and AP3S2 in small intestine are also uncorrelated ( Figure 6B ). However, the genetically predicted gene 243 expression values for the RCCD1 in brain cortex and PRC1 in pancreas (the top model for this reported 244 T2D gene), are strongly and negatively correlated with each other, consistent with their directions of 245 association with T2D ( Figure 6A-B) . The predictive models underlying these associations share three 246 SNPs in common (rs2290202, rs2285937, and rs3743445) that are associated with increased expression of 247 RCCD1 in brain cortex and decreased expression of PRC1 in pancreas ( Figure 6D-E,G) . Therefore, the We performed a large-scale, in silico study of predicted gene expression across a comprehensive set of 267 human tissues to prioritize genes that alter the risk of T2D through regulation of gene expression levels. 268 We corroborated many of the known T2D genes, which supports the role of regulation of gene expression 269 levels as a key mediating mechanism, but also found novel genes both in known loci as well as in completely 270 novel loci. Replication in an independent cohort gives further support to our results.
271
Among novel genes of interest are genes previously linked to related traits such as HKDC1 (pregnancy- 
281
Averaging across the genome, we found that diabetes relevant tissues such as liver, pancreas, adipose, 282 and muscle are enriched with significant associations. However, when we look into individual genes 283 at the top significance level we found associations in tissues that are not typically linked to diabetes.
284
For example, TCF7L2 was significantly associated only in aortic artery and adrenal gland, which is a 285 consequence of the fact that with GTEx samples active regulation of this gene was only found in these 286 tissues.
287
Most associations were discovered in a few tissues indicating strong context specificity. Some of the 288 associations may be pointing to a real causal tissue but others are likely to be a consequence of shared 
where w l,g represents the prediction model weight for SNP l on gene g, l is the standard deviation for 393 SNP l,ˆ g is the standard deviation of predicted expression for gene g,ˆ l is the regression coe cient for 394 the regression of expression on the allelic dosage of SNP l.
395
In our MetaXcan analyses of T2D, we use regression coe cients (ˆ l ) from results from the trans-ethnic 396 meta-analysis of GWAS and the GWAS on T2D from the GERA study. Values for w l,g were generated 397 as described above and available from the PredictDB website (http://predictdb.org).ˆ 2 g is estimated as:
Where W g is the vector of w l,g for SNPs in the model of g and Var(X g ) is the covariance matrix of 400 X g . We use SNP information from a 1000 Genome Project reference panel (European ancestry) to the 401 compute the variances and covariances of the SNPs used to predict gene expression.
402
Locus analysis of T2D-associated regions 403 We first identified a set of 111 reported T2D genes based on their being the most proximal to T2D-404 associated SNPs at p < 5 ⇥ 10 6 in the trans-ethnic meta-analysis of GWAS. We then delineated genomic 405 regions for each reported gene by taking the set of all significantly-associated SNPs annotated to that 406 gene and demarcating a window bounded by the SNPs most distal to each other. We then expanded the 407 region by 1 Mb upstream and downstream of the "boundary" SNPs. This ensured that the reported gene 408 was included within the genomic window corresponding to the T2D-associated locus. This procedure 409 resulted in 68 non-overlapping genomic regions (i.e. windows).
410
We then performed a genome-wide MetaXcan analysis of the trans-ethnic study to test for association 411 between predicted expression for each gene with prediction FDR  0.05 (from the regression of observed 412 gene expression on predicted gene expression) in each of the 44 tissue models described above. When 413 visualizing the MetaXcan results at each T2D locus we considered two significance thresholds: (1) genome-414 wide significance correcting for the total number of tests performed across all available tissue models and
415
(2) significance correcting for the number of tests performed within each non-overlapping region.
Meta-analysis of association results from the MetaXcan analysis of trans-417 ethnic and GERA cohorts 418 We performed a sample-sized based meta-analysis [54] of the association results from our MetaXcan 419 analyses of the trans-ethnic and GERA studies where the Z-score (Z) was given by:
where Z i = 1 (P i /2) ⇤ sign( i ), P i is the p-value for study i, w i = p (N i ), N i refers to the sample size 421 for study i, i is the direction of e↵ect in study i, and the overall P-value is given by: 
